✦ LIBER ✦

Small-sized adenocarcinoma of the lung

✍ Scribed by Morishita, Yukio ;Fukasawa, Masakatsu ;Takeuchi, Mika ;Inadome, Yukinori ;Matsuno, Yoshihiro ;Noguchi, Masayuki

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 747 KB
Volume: 93
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.9018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chymase-positive mast cells in small siz

Chymase-positive mast cells in small sized adenocarcinoma of the lung

✍ Manabu Nagata; Noriharu Shijubo; AndrewF Walls; Shingo Ichimiya; Shosaku Abe; No 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 435 KB

p16 inactivation in small-sized lung ade

p16 inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis

✍ Beniyo Kawabuchi; Sachiko Moriyama; Mitsugu Hironaka; Takeshi Fujii; Morio Koike 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB

p16, an inhibitor of cell cycle machinery, is frequently inactivated in non-small cell carcinoma of the lung (NSCCL). To clarify the significance of p16 inactivation in the progression of lung adenocarcinoma, we immunohistochemically evaluated p16 protein status and Rb, p53 and cyclin D1 expression

Cytopathologic factors can predict invas

Cytopathologic factors can predict invasion in small-sized peripheral lung adenocarcinoma with a bronchioloalveolar carcinoma component

✍ Maezawa, Naoki ;Tsuta, Koji ;Shibuki, Yasuo ;Yamazaki, Shigeki ;Maeshima, Akiko 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

Adenocarcinoma of the lung: Clinicopatho

Adenocarcinoma of the lung: Clinicopathological study

✍ Patrick Marabella; Hiroshi Takita 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Adenocarcinoma of the small bowel

✍ Robert R. Hutchins; Ahmed Bani Hani; Pipin Kojodjojo; Robyn Ho; Steven J. Snooks 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Cancer of the small bowel is a rare entity but its incidence is rising. Historically, outcome is poor despite apparent curative resection. At present surgery remains the only treatment modality of proven benefit in the management of this disease. Recent data would suggest 5‐year survival rates in th

Adenocarcinoma of the Small Bowel

✍ Neil A. Abrahams; Amy Halverson; Victor W. Fazio; Lisa A. Rybicki; John R. Goldb 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 494 KB